In this study, we assessed the role of TIL markers (CD3, CD4, CD8, and FOXP3) in a large cohort of patients with pure tongue squamous cell carcinoma receiving maximal curative treatment involving radical surgery and adjuvant RT or adjuvant CCRT. This evidence concerns the gene CD4 and tongue squamous cell carcinoma.